PTEN gene mutation and high MIB-1 labeling index may contribute to dissemination in patients with glioblastoma

Journal of Clinical Neuroscience

Volumn 11, Issue 1, 2004, Pages 37-41

  Kato, Hideaki ^a,b   Fujimura, Miki ^a   Kumabe, Toshihiro ^a   Ishioka, Chikashi ^b   Kanamaru, Ryunosuke ^b   Yoshimoto, Takashi ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

Dissemination; Glioblastoma; MIB 1 labeling index; Prognosis; PTEN

Indexed keywords

COMPLEMENTARY DNA; MONOCLONAL ANTIBODY KI 67; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISSEMINATED CANCER; DNA SEQUENCE; EVALUATION; FEMALE; GENE MUTATION; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME;

EID: 0345169950     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2002.09.001     Document Type: Article

References (34)

1. Elliott JP, Keles GE, Waite M, Temkin N, Berger MS. Ventricular entry during resection of malignant gliomas: effect on intracranial cerebrospinal fluid tumor dissemination. J Neurosurg 1994; 80: 834-839.
2. Kandt RS, Shinnar S, D'Souza BJ, Singer HS, Wharam MD, Gupta PK. Cerebrospinal metastases in malignant childhood astrocytomas. J Neurooncol 1984; 2: 123-128.
3. Packer RJ, Siegel KR, Sutton LN, Litmann P, Bruce DA, Schut L. Leptomeningeal dissemination of primary central nervous system tumors of childhood. Ann Neurol 1985; 18: 217-221.
4. Awad I, Bay JW, Rogers L. Leptomeningeal metastasis from supratentorial malignant gliomas. Neurosurgery 1986; 19: 247-251.
5. Vertosick FT, Selker RG. Brain stem and spinal metastases of supratentorial glioblastoma multiforme: a clinical series. Neurosurgery 1990; 27: 516-522.
6. Grabb PA, Albright AL, Pang D. Dissemination of supratentorial malignant gliomas via the cerebrospinal fluid in children. Neurosurgery 1992; 30: 64-71.
7. Arita N, Taneda M, Hayakawa T. Leptomeningeal dissemination of malignant glioma. Incidence, diagnosis and outcome. Acta Neurochir (Wien) 1994; 126: 84-92.
8. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH, Parsons R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997; 275: 1943-1947.
9. Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DH, Tavtigian SV. Identification of a candidate tumour suppressor gene, MMACI, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 1997; 1: 356-362.
10. Rasheed BK, Stenzel TT, McLendon RE, Parsons R, Friedman AH, Friedman HS, Bigner DD, Bigner SH. PTEN gene mutations are seen in high-grade but not in low-grade gliomas. Cancer Res 1997; 7: 4187-4190.
11. Wang SI, Puc J, Li J, Bruce JN, Cairns P, Sidransky D, Parsons R. Somatic mutations of PTEN in glioblastoma multiforme. Cancer Res 1997; 57: 4183-4186.
12. Duerr EM, Rollbrocker B, Hayashi Y, Peters N, Meyer-Puttlitz B, Louis DN, Schramm J, Wiestler OD, Parsons R, Eng C, von Deimling A. PTEN mutations in gliomas and glioneuronal tumors. Oncogene 1998; 16: 2259-2264.
13. Kato H, Kato S, Kumabe T, Sonoda Y, Yoshimoto T, Kato S, Han SY, Suzuki T, Shibata H, Kanamaru R, Ishioka C. Functional evaluation of p53 and PTEN gene mutations in gliomas. Clin Cancer Res 2000; 6: 3937-3943.
14. Tamura M, Gu J, Danen EH, Takino T, Miyamoto S, Yamada KM. PTEN interactions with focal adhesion kinase and suppression of the extracellular matrix-dependent phosphatidylinositol3-kinase/Akt cell survival pathway. J Biol Chem 1999; 274: 20693-20703.
15. Rezai AR, Woo HH, Lee M, Cohen H, Zagzag D, Epstein FJ. Disseminated ependymomas of the central nervous system. J Neurosurg 1996; 85: 618-624.
16. Kleihues P, Burger PC, Scheithauer BW (eds). Histological Typing of Tumors of the Central Nervous System, second edn. World Health Organization. International Histological Classification of Tumors. Springer, New York; 1993.
17. Shi SR, Key ME, Kalra KL. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 1991; 39: 741-748.
18. Erlich SS, Davis RL. Spinal subarachnoid metastasis from primary intracranial glioblastoma multiforme. Cancer 1978; 42: 2854-2864.
19. Yung WA, Horten BC, Shapiro WR. Meningeal gliomatosis: a review of 12 cases. Ann Neurol 1980; 8: 605-608.
20. Salazar OM, Rubin P. The spread of glioblastoma multiforme as a determining factor in the radiation treated volume. Int J Radiat Oncol Biol Phys 1976; 1: 627-637.
21. Nakada M, Kita D, Futami K, Yamashita J, Fujimoto N, Sato H, Okada Y. Roles of membrane type I matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma. J Neurosurg 2001; 94: 464-473.
22. Izumoto S, Ohnishi T, Kanemura H, Arita N, Maruno M, Moriuchi T, Suzuki S, Yoshimine T. PTEN mutations in malignant gliomas and their relation with meningeal gliomatosis. J Neurooncol 2001; 53: 21-26.
23. Tamura M, Gu J, Matsumoto K, Aota S, Parsons R, Yamada KM. Inhibition of cell migration spreading and focal adhesions by tumor suppressor PTEN. Science 1998; 280: 1614-1617.
24. Gu J, Tamura M, Yamada KM. Tumor suppressor PTEN inhibits integrin-and growth factor-mediated mitogen-activate protein (MAP) kinase signaling pathways. J Cell Biol 1998; 143: 1375-1383.
25. Maier D, Jones G, Li X, Schonthal AH, Gratzl O, Van Meir EG, Merlo A. The PTEN lipid phosphatase domain is not required to inhibit invasion of glioma cells. Cancer Res 1999; 59: 5479-5482.
26. Komiya A, Suzuki H, Ueda T, Yatani R, Emi M, Ito H, Shimazaki J. Allelic losses at loci on chromosome 10 are associated with metastasis and progression of human prostate cancer. Genes Chromosomes Cancer 1996; 17: 245-253.
27. Petersen S, Wolf G, Bockmuhl U, Gellert K, Dietel M, Petersen I. Allelic loss on chromosome 10q in human lung cancer: association with tumour progression and metastatic phenotype. Br J Cancer 1998; 70: 270-276.
28. Guldberg P, thor Straten P, Birck A, Ahrenkiel V, Kirkin AF, Zeuthen J. Disruption of the MMACI/PTEN gene by deletion or mutation is a frequent event in malignant melanoma. Cancer Res 1997; 57: 3660-3663.
29. Suzuki H, Freije D, Nusskern DR, Okami K, Cairns P, Sidransky D, Isaacs WB, Bova GS. Interfocal heterogeneity of PTEN/MMACI gene alterations in multiple metastatic prostate cancer tissues. Cancer Res 1998; 58: 204-209.
30. Hahn M, Wieland I, Koufaki ON, Gorgens H, Sobottka SB, Schackert G, Schackert HK. Genetic alterations of the tumor suppressor gene PTENI/ MMACI in human brain metastases. Clin Cancer Res 1999; 5: 2431-2437.
31. Sano T, Lin H, Chen X, Langford LA, Koul D, Bondy ML, Hess KR, Myers JN, Hong YK, Yung WK, Steck PA. Differential expression of MMAC/PTEN in glioblastoma multiforme: relationship to localization and prognosis. Cancer Res 1999; 59: 1820-1824.
32. Lin H, Bondy MA, Steck PA. Allelic deletion analyses of MMAC/PTEN and DMBT I loci in gliomas: relationship to prognostic significance. Clin Cancer Res 1998; 4: 2447-2454.
33. Raffel C, Frederick L, O'Fallon JR, Atherton-Skaff P, Perry A, Jenkins RB, James CD. Analysis of oncogene and tumor suppressor gene alterations in pediatric malignant astrocytomas reveals reduced survival for patients with PTEN mutations. Clin Cancer Res 1999; 5: 4085-4090.
34. Hoshi M, Yoshida K, Shimazaki K, Sasaki H, Otani M, Kawase T. Correlation between MIB-I staining indices and recurrence in low-grade astrocytomas. Brain Tumor Pathol 1997; 14: 47-51.